Wade M Junker
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.2MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 21, 2019 | NIH | SBIR Phase I Combinatorial Biomarkers for Malignant Polyps and Colon Cancer Detection | $225K | Sanguine Diagnostics And Therapeutics, Inc. |
| Sep 13, 2018 | NIH | SBIR Phase II Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer | $650K | Sanguine Diagnostics And Therapeutics, Inc. |
| Feb 28, 2018 | NIH | SBIR Phase II Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer | $197K | Sanguine Diagnostics And Therapeutics, Inc. |
| Feb 28, 2018 | NIH | SBIR Phase II MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases | $658K | Sanguine Diagnostics And Therapeutics, Inc. |
| Sep 8, 2017 | NIH | SBIR Phase II MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases | $199K | Sanguine Diagnostics And Therapeutics, Inc. |
| Sep 13, 2016 | NIH | STTR Phase I Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis | $300K | Sanguine Diagnostics And Therapeutics, Inc. |
Peer ranks
Federal funding#1,000
Awards as PI#349
Patents#505
Companies
- Sanguine Diagnostics And Therapeutics, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.